METHYL (3S)-3-(2-CHLOROPYRIDIN-4-YL)-3-CYCLOPROPYLPROPANOATE, 95.0%, 250mg

tert-Butyl 7-formyl-8-hydroxy-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxylate, 97%, 250mg

ETHYL 2-(4-BROMO-2-CHLOROPHENOXY)ACETATE, 95.0%, 5g

Round filters Type, MN 617 G phosphate-free, , 320 mm, 100 Piece(s)

(R)-3-((tert-Butoxycarbonyl)amino)-3-(3-cyanophenyl)propanoic acid, 95.0%, 1g

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 100, 2000 ml, 160 mm, 1 Piece

PD-161570>98.0%(HPLC)25mg

3-Bromoindazole, 95.0%, 1g

4-(5-Formyl-furan-2-yl)-benzonitrile, 10g

2,3-DICHLORO-N-(3-METHOXYPYRAZIN-2-YL)BENZENESULFONAMIDE, 95%, 25mg

1H-Pyrrole-2-carboxamide, 95.0%, 1g

2-Bromoanthraquinone, 97.0%, 100g

FNIII 14 Peptide>70.0%(HPLC)5mg